ZOTANSEZota Health Care LImited· Pharmaceuticals & BiotechnologyHighNeutral
Announced Wed, 4 Feb, 2026 · 19:10 IST

Zota Health Care Limited has submitted to the Exchange, the financial results for the quarter and nine months ended December 31, 2025.

ZOTA · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
-2.8%Reaction day
₹1333.00
prior close
₹1330.00
announcement price
After-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used-1.0%-1.8% vs market
Pharmaceuticals peers, median of 157sector-0.5%-2.3% vs sector

On the reaction day the stock moved 1.8 pts less than Nifty Microcap 250 and 2.3 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
-1.9
10m
-2.2
15m
-2.3
30m
-2.3
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
-2.8-1.0-1.8-0.5-2.3
Next day
-3.8-1.8-2.0-1.2-2.6
2d
+0.0+0.8-0.8+0.6-0.6
3d
+3.3+1.8+1.5+1.0+2.3
4d
+5.0+1.2+3.8+0.9+4.2
5d
+6.0+0.7+5.3+0.0+6.0
1w
+2.8-1.5+4.3-1.5+4.3
15d
-6.8-2.5-4.4-2.9-3.9
1m
-8.5-7.2-1.3-5.0-3.4
2m
-15.1-8.9-6.2-7.3-7.8
3m
-1.8+5.5-7.3+0.4-2.2
UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 157Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Zota Health Care Limited has filed its financial results for the third quarter and nine months ended December 31, 2025 with the stock exchange. This is a standard regulatory submission under listing requirements. The announcement itself does not include the actual financial figures — those are contained in the separate results document. No details on revenue, profit, margins, or auditor observations are mentioned in this filing notice.

Likely market impact

Investors should refer to the detailed Q3 and 9M FY26 results document for actual numbers and performance trends. By itself, this announcement is a procedural filing and is unlikely to move the stock price.